KHK7791

· Kyowa Kirin Co., Ltd.

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for KHK7791, covering 2021-09-08 to 2024-03-07. Get the full timeline:

Most recent: Clinical Trial Update: Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients [Phase 2]